+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Neurocardiology. The Emerging Field of Brain/Heart Interactions

  • Book

  • June 2024
  • Elsevier Science and Technology
  • ID: 5917464
Neurocardiology: The Emerging Field of Brain/Heart Interactions addresses important questions and directions for research that lie at the intersection of cardiovascular care and brain science. In addition, the book provides clinicians with guidance for the care of patients with neurological and cardiovascular disorders, including stroke, dementia, and the management of cardiac causes of these conditions. The past decade has witnessed dramatic changes in the overlapping space between cardiovascular care and brain health and science. Treatment of high blood pressure has been demonstrated to reduce cognitive impairment and dementia.

Subclinical cardiac disorders, including atrial fibrillation, atrial cardiopathy, and patent foramen ovale, are increasingly recognized as modifiable risk factors and causes of stroke; related treatments, such as left atrial exclusion and PFO closure, have become standard of care. Techniques developed originally in the treatment of acute myocardial infarction 30 or more years ago have now become evidence-based standard of care for patients with acute ischemic stroke.

Table of Contents

1. Brain Science/Heart Science: Exploring the Boundaries
2. What is Neurocardiology?
3. Enhancing cooperation between neurology and cardiology services
4. Cardiac evaluation of the stroke patient: Standardizing approaches
5. Atrial Fibrillation and Stroke: The Paradigmatic Connection Between the Heart and the Brain
6. Searching for Atrial Fibrillation after Stroke
7. The Burden of Atrial Fibrillation and Risk of Stroke
8. Left atrial appendage exclusion as a treatment for AF-related stroke
9. The coexistence of cerebral amyloid angiopathy and atrial fibrillation: Clinical Approaches
10. Atrial fibrillation and dementia: Coincidence or cause?
11. Aging heart, aging brain: Heart failure, stroke, and cognition
12. Atrial cardiopathy and stroke risk: Separating facts from hypotheses
13. Patent Foramen Ovale as a cause of stroke
14. Closure of Patent Foramen Ovale for stroke prevention
15. Aortic arch atheroma and stroke: state of the science
16. Unusual cardiac causes of stroke: fibroelastoma, myxoma, bicuspid aortic valve, aortic valve calcification
17. Thrombophilia and stroke risk: Diagnostic considerations
18. Antithrombotic therapy in patients with stroke and ischemic heart disease
19. Effects of brain injury on cardiac function: Takotsubo cardiomyopathy, sudden cardiac death
20. Neurological complications of cardiac transplantation
21. Endovascular carotid treatment approaches for hypertension management
22. Heart vessels, brain vessels: differential mechanisms in vascular remodeling
23. Insights from cardiovascular research into brain physiology
24. Insights from neuroscience research into cardiac physiology
25. Insights from Emergency Cardiovascular Care and Stroke Systems of Care/Mobile Stroke Units
26. Directions for future research in Neurocardiology

Authors

Mitchell S.V. Elkind tenured Professor of Neurology and Epidemiology at Columbia University, and Chief of the Division of Neurology Clinical Outcomes Research and Population Sciences (Neuro CORPS) in the Neurology Department.. Mitchell Elkind, MD, MS is a tenured Professor of Neurology and Epidemiology at Columbia University, and Chief of the Division of Neurology Clinical Outcomes Research and Population Sciences (Neuro CORPS) in the Neurology Department. Dr. Elkind received his medical degree from Harvard Medical School and trained in Internal Medicine at Brigham and Women's Hospital and in Neurology at Massachusetts General Hospital, both in Boston, MA. He completed a fellowship in Vascular Neurology and Neuroepidemiology at Columbia University Medical Center under the mentorship of Dr. Ralph Sacco. Dr. Elkind holds a Master's degree in Epidemiology from Columbia's Mailman School of Public Health. His research focuses on stroke prevention, inflammatory and infectious biomarkers in stroke risk prediction, atrial cardiopathy, immune therapy for acute stroke, and vascular causes of cognitive aging. He has published over 600 articles on stroke, dementia, cardiac diseases, and related topics. Dr. Elkind served as President of the American Heart Association (AHA) 2020-2021, and he is currently the Immediate Past President. He co-chaired the writing committee for the 2012 scientific statement on the inclusion of stroke as an outcome and risk equivalent in vascular disease risk scores, and currently serves as co-chair of the stroke section of the annual statistical update.